Chemoprophylaxis of SARS-CoV-2 Infection (COVID-19) in Exposed Healthcare Workers

NCT04328285 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

118

Enrollment

OTHER

Sponsor class

Stopped French authority's decision

Conditions

COVID-19

Interventions

DRUG: Hydroxychloroquine
DRUG: Placebo of Hydroxychloroquine
DRUG: Lopinavir and ritonavir
DRUG: Placebo of LPV/r Tablets

Sponsor

Centre Hospitalier Universitaire de Saint Etienne

Collaborators

[object Object]